ProActive Search
Loading

Subscribe by Email to ProActive Blog

Your email:

ProActive Tweets

ProActive @ Stock Twits

ProActive Emerging Life Science Index

May 9, 2012

Index Value 1,540. 00

Daily Change 3.11%

Year To Date +2.22%

ProActive Social Media

google feedburner

proactive newsroom facebook  
proactive linkedin proactive youtube  

proactive twitter

slide share proactive  

ProActive Rankings

Contact ProActive

VeoMed Tweets

Stock Newsroom, Small Cap Stock Research, Small Cap Stocks To Watch

Current Articles | RSS Feed RSS Feed

Maureen Dowd of NY Times Addresses Hospital Infections ($BONU)

  
  
  

In the modern world, many "causes" need a "Champion" to push that cause into the public's psyche. AIDS had Elizabeth Taylor and Austim has Bob Wright former President of NBC.

maureen dowdMaureen Dowd of the New York Times is a winner of the 1999 Pulitzer Prize for distinguished commentary, and became a columnist on The New York Times Op-Ed page in 1995. Yesterday, Ms. Dowd wrote a very interesting and very personal Op-Ed column on hospital infections. It stated:

"When my brother went into the hospital with pneumonia, he quickly contracted four other infections in the intensive care unit. Anguished, I asked a young doctor why this was happening. Wearing a white lab coat and blue tie, he did a show-and-tell. He leaned over Michael and let his tie brush my sedated brother’s hospital gown. “It could be anything,” he said. “It could be my tie spreading germs.” Michael died in that I.C.U."

Dowd also states:

  • Infections kill 100,000 patients in hospitals and other clinics in the U.S. every year.
  • The Centers for Disease Control and Prevention says that health care workers, even doctors and nurses, have a “poor” record of obeying hand-washing rules.
  • A report in the April issue of Health Affairs indicated that one out of every three people suffer a mistake during a hospital stay.

BioNeutral Group (OTCBB: BONU; Twitter: $BONU) is a bonuspecialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene™ and Ogiene™, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. 

Perhaps Ms Dowd and others can become champions of the issues surrounding hospital infections as the hospital market is a significant potential opportunity for BioNeutral.

proactive capital

ProActive Capital Indexes

See ProActive's Disclaimer

Comments

We are a privately held company in California that has developed a technology platform in this same arena and have access to another technology that addresses urinary tract infections which account for over 40% of all hospital acquired infections.
Posted @ Wednesday, April 13, 2011 5:24 PM by Patrick Hurst
We know Ygiene is a great product but the world is still waiting for the Bioneutral Group to produce it....
Posted @ Thursday, April 14, 2011 7:51 PM by Ken Benedict
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics